Call 408.493.1800 | Fax 408.493.1801 | Toll Free 800.891.9699 (US Only) | Email: [email protected]

Acetylcholinesterase Inhibitor Screening Kit (Colorimetric)

November 2018

Acetylcholinesterase Inhibitor Screening Kit (Colorimetric)

FOR IMMEDIATE RELEASE

MILPITAS, Calif. - Nov. 19, 2018 - PRLog -- Acetylcholinesterase (AChE; EC 3.1.1.7) is the main cholinesterase enzyme in the nervous system. It is responsible for the hydrolysis of acetylcholine and some other choline esters that function as neurotransmitters. AChE is highly expressed in both the brain and the peripheral nervous system. It is especially enriched at neuromuscular junctions, where its activity serves to terminate synaptic transmission between motor neurons and skeletal muscles. Reversible inhibitors of AChE (such as donepezil, rivastigmine and galantamine) are commonly used in the treatment of Alzheimer's Disease and other neurodegenerative disorders. However, irreversible inhibitors of AChE tend to be extremely poisonous, causing muscular paralysis, convulsions, bronchial constriction and eventual death by asphyxia. BioVision's Acetylcholinesterase Inhibitor Screening Kit can be used to screen for potential inhibitors of AChE activity. It utilizes the ability of an active human AChE enzyme to hydrolyze the provided colorimetric substrate, generating a yellow chromophore that can be detected by measuring absorbance at 412 nm. In the presence of the potent reversible AChE inhibitor donepezil, enzyme activity is suppressed, preventing chromophore generation. The assay kit is adapted to a 96-well format and provides a rapid, simple and reliable test for high-throughput screening of AChE inhibitors.


Figure: Inhibition of Acetylcholinesterase activity by Donepezil. IC50 of Donepezil was calculated to be 31.5 ± 2.3 nM. Assay was carried out following the kit protocol.

For complete information on this product, visit: https://www.biovision.com/acetylcholinesterase-inhibitor-...



About BioVision:

BioVision, Inc. is a privately held Life Science company headquartered in the beautiful San Francisco Bay area. BioVision develops and offers a wide variety of products including assay kits, antibodies, recombinant proteins & enzymes, and other innovative research tools for studying Apoptosis, Metabolism, Cell Proliferation, Cellular Stress, Cell Damage and Repair, Diabetes, Obesity and Metabolic Syndrome, Stem Cell Biology, Gene Regulation, Signal Transduction, and more.


Media Contact
BioVision Marketing
***@biovision.com
408493180022

« Back